Award recordCONTRACT

WALGREENS SPECIALTY PHARMACY, LLC

PIID 36C26120P0495· VHA· 261-NETWORK CONTRACT OFFICE 21 (36C261)· 6505 · DRUGS AND BIOLOGICALS· FY2020· $40,409 net obligations· UEI EBASWPM7BVB8· PA

Description

TOLVAPTAN. THIS MOD P0002 ADDS BACK FUNDS FOR 4TH DOSE TO BE INVOICED AND CLOSE OUT ORDER.

Base award description: TOLVAPTAN

First action · last action
2020-01-31 · 2022-09-07
Transactions
3
First transaction's obligation
$40,409
Base + all options value (sum of deltas)
$40,409
Extent competed
NOT COMPETED
Other than full & open authority
URGENCY (FAR 6.302-2)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$40,409$0Base award · 2020-01-31 · this action $40,409 · running total $40,409Modification P00001 · 2020-12-22 · this action -$10,102 · running total $30,307Modification P00002 · 2022-09-07 · this action $10,102 · running total $40,409
  • Base2020-01-31+$40,409= $40,409
  • Mod P000012020-12-22-$10,102= $30,307
  • Mod P000022022-09-07+$10,102= $40,409
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2020-01-31+$40,409$40,409TOLVAPTAN
Mod P00001· FUNDING ONLY ACTION2020-12-22−$10,102$30,307TOLVAPTAN
Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2022-09-07+$10,102$40,409TOLVAPTAN. THIS MOD P0002 ADDS BACK FUNDS FOR 4TH DOSE TO BE INVOICED AND CLOSE OUT ORDER.

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI EBASWPM7BVB8)

AwardOffice · PSC / listingNet obligationsFY
36C24226P0262242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$13,243FY2026
36C24226P0199242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$13,243FY2026
36C24226P0033242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$13,243FY2026
36C24225P1476242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$13,243FY2025
36C24225P1475242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$13,243FY2025
36C24225P1301242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$13,243FY2025

Other recipients under 6505 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26126P1178OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026
36C26126P1102ENVIGO RMS LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$74,586FY2026
36C26126P096110X GENOMICS, INC.261-NETWORK CONTRACT OFFICE 21 (36C261)$34,600FY2026
36C26126P0997SIERRA RADIOPHARMACY LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$247,204FY2026
36C26126P1008OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26120P0495_3600_-NONE-_-NONE- · retrieved 2026-09-26.